Overall survival and effect of pretreatment status and hematologic response on survival. (A) Overall survival for all patients from diagnosis of amyloidosis. (B) Overall survival from beginning of CTD chemotherapy stratified by newly diagnosed and relapsed/refractory patients. (C) Overall survival from end of CTD chemotherapy according to degree of hematologic response. (D) Effect of pretreatment eligibility for stem cell transplantation on overall survival from the end of CTD chemotherapy, stratified by hematologic response.